Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability

NCT01211197 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: C: BI 10773 / metformin tablet
DRUG: B: BI 10773 tablet and metformin tablet
DRUG: A: BI 10773 / metformin tablet

Sponsor

Boehringer Ingelheim